R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division...

27
R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital Camden, New Jersey Professor of Medicine Cooper Medical School of Rowan University

Transcript of R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division...

Page 1: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

R. Phillip Dellinger, MD, MCCM, FCCPActing Chair & Chief of Department of MedicineHead, Division of Critical Care MedicineCooper University Hospital Camden, New Jersey

Professor of Medicine Cooper Medical School of Rowan University

Page 2: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

What’s new with the 2012 guidelines and

associated changes in the database

R. Phillip Dellinger MD, MCCMChrista A. Schorr RN, MSN, FCCM

Cooper Medical School Rowan UniversityCooper University Hospital

Camden, NJ

Page 3: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

Potential Conflicts of Interest

• Neither has direct or indirect potential financial conflict of interest as to any material presented in this presentation

• As to potential intellectual conflict of interest both hold leadership positions in Surviving Sepsis Campaign

Page 4: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

R. Phillip Dellinger, Mitchell M. Levy, Andrew Rhodes, Djillali Annane, Herwig Gerlach, Steven M. Opal, Jonathan E. Sevransky, Charles L. Sprung,

Ivor S. Douglas, Roman Jaeschke, Tiffany M. Osborn, Mark E. Nunnally, Sean R. Townsend, Konrad Reinhart, Ruth M. Kleinpell, Derek C. Angus,

Clifford S. Deutschman, Flavia R. Machado,Gordon D. Rubenfeld, Steven A. Webb, Richard J. Beale, Jean-Louis Vincent, Rui Moreno, and the Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup.

Crit Care Med 2013; 41:580-637 Intensive Care Medicine 2013; ..

Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2012

Page 5: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

Currently Funded with a Gordon and Betty Moore Foundation Grant

No direct or indirect industry support for guidelines revision

Page 6: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

Grading Quality of EvidenceGRADE System

• A- high quality

• B- intermediate

• C- low

• D- very low

– Case series or expert opinion

• Upgrade capability

• Ungraded (UG) recommendation

Page 7: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

Grading Strength of RecommendationGRADE System

• 1- strong recommendation – We recommend

• 2- weak recommendation – We suggest

Page 8: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

Early Screening and a Performance Improvement Program

Page 9: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

Antibiotic Therapy

• We recommend that intravenous antibiotic therapy be started as early as possible and within the first hour of recognition of septic shock (1B) and severe sepsis without septic shock (1C).(Best Practice versus Stand of Care)

Page 10: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

Resuscitation of Sepsis Induced Tissue Hypoperfusion

• Recommend MAP 65 mm Hg

Page 11: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

FLUID THERAPY

Page 12: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

Fluid therapy

1. We recommend crystalloids be used in the initial fluid resuscitation of severe sepsis (Grade 1B).

Page 13: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

Fluid therapy

1. We suggest the use of albumin in the fluid resuscitation of severe sepsis and septic shock when patients require substantial amounts of crystalloids (Grade 2C).

Page 14: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

Fluid challenge

Initial fluid challenge in sepsis-induced tissue hypoperfusion (hypotension or elevated

lactate) A minimum of 30ml/kg of crystalloids

(a portion of this may be albumin equivalent). (1B)

Page 15: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

Vasopressors

Page 16: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

Vasopressors

1. We recommend norepinephrine as the first choice vasopressor (Grade 1 B).

Page 17: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

Vasopressors

2. We suggest epinephrine (added to and potentially substituted for norepinephrine) when an additional agent is needed to maintain blood pressure (Grade 2B).

Page 18: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

Vasopressors

3. Vasopressin .03 units/min can be added to norepinephrine with the intent of raising MAP to target or decreasing or decreasing norepinephrine dosage.

(UG)

Page 19: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

Phenylephrine

Pure vasopressor and in general not recommended

Page 20: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

Sepsis Induced Tissue Hypoperfusion(Recommend Quantitative

Resuscitation) Requirement for vasopressors after fluid

challenge

or

Lactate ≥ 4 mg/dL

Page 21: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

Initial Resuscitation of Sepsis Induced Tissue Hypoperfusion

Recommend Insertion central venous catheter• Central venous pressure: 8–12 mm Hg

• Higher with altered ventricular compliance or increased intrathoracic pressure

Grade 1C

Page 22: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

Arterial Systolic Pressure Variation

Parry-Jones, et al. Int J Respir Crit Care Med 2003;2:67

Page 23: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

Part

At

Effect on Stroke Volume

Page 24: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

Effect on Stroke Volume

Page 25: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

Effect on Cardiac Filling

Page 26: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

Initial Resuscitation of Sepsis Induced Tissue Hypoperfusion

Recommend Insertion central venous catheter• ScvO2 saturation (SVC) 70%Grade 1C

Page 27: R. Phillip Dellinger, MD, MCCM, FCCP Acting Chair & Chief of Department of Medicine Head, Division of Critical Care Medicine Cooper University Hospital.

Lactate Clearance

In patients with elevated lactate levels as amarker of tissue hypoperfusion we suggesttargeting resuscitation to normalize lactate asrapidly as possible (grade 2C).